Constance Therapeutics' Unattributed - III Round

Constance Therapeutics raised a round of funding on March 05, 2018.

Constance Therapeutics produces whole plant cannabis extracts as part of an integrative approach to treatment called Care 2.0. This provides physicians and their patients with expanded treatment optio…

Articles about Constance Therapeutics' Unattributed - III Round: